This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|July 1, 2015
Merck Millipore celebrates 40 years of first class sterility testing solutions
In 1974, Merck Millipore was the first to market a closed filtration device: Steritest?. Since this time, through dedicated research & development, we have been instrumental in raising the industry?s standards ? reducing the risk of false positive and negative results, increasing reliability and improving workflow for microbiologists around the world.
Advertisement
Merck Millipore celebrates 40 years of first class sterility testing solutions
In 1974, Merck Millipore was the first to market a closed filtration device: Steritest™. Since this time, through dedicated research & development, we have been instrumental in raising the industry's standards – reducing the risk of false positive and negative results, increasing reliability and improving workflow for microbiologists around the world.
We are a one-stop shop that offers an extensive portfolio of quality control products, as well as preventive maintenance, training, validation support and much more.
As we step into the future, Merck Millipore will continue providing reliable high quality products and comprehensive first-class services.
Our latest offer: a rapid sterility testing solution providing results within only 5 days.
40 years is just the beginning
“Conducting a test for sterility requires excellent work flows and a reliable test performance. The Merck Millipore SteritestTM system, with pump and filtration devices, supports the operators in a perfect manner to obtain reliable test results.”
Dr. Timo Krebsbach, Divison Manager Marketing & Sales, Labor L+S AG
Advertisement
Related to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement